Institutional investors purchased a net $86.4 thousand shares of NVGN during the quarter ended June 2016 and now own 1.88% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 34.9 Thousand shares of Novogen Ltd
KCG AMERICAS LLC Bought 23.7 Thousand shares of Novogen Ltd
CITADEL ADVISORS LLC Bought 17.6 Thousand shares of Novogen Ltd